Clinicians advised to halt use of propofol from tainted lots

Back to Collections Results Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Clinicians advised to halt use of propofol from tainted lots

Record #: 125 of 416

Published Date:

7/9/09

Series:

HAN ; 296

Language:

English

[PDF-505.03 KB]

Details:

Corporate Authors:

Centers for Disease Control and Prevention (U.S.) . United States. Food and Drug Administration. .

Keywords:

[+]

Description:

Monday, July 13, 2009, 19:00 EDT (7:00 PM EDT)

CDCHAN-00296-2009-07-13-ADV-N

The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have been investigating recent cases of febrile reactions among patients undergoing endoscopy in the United States.

This investigation has revealed that all of the case-patients received the anesthetic propofol from 100 ml vials manufactured byTeva Pharmaceuticals.

Testing done by the FDA has found that two lots of this product that were in use in facilities reporting febrile reactions were positive for elevated levels of endotoxin.

The lots are 31305429B and 31305430B.

Teva Pharmaceuticals is initiating a voluntary recall for these lots, and clinicians are advised to immediately stop using these lots of Teva Pharmaceuticals propofol.

CDC, FDA and Teva Pharmaceuticals are continuing to investigate this issue.

Document Type:

HAN Health Advisory

Collection(s):

Health Alert Network (HAN)

Place as Subject:

United States

Supporting Files:

No Additional Files

No Related Documents.

You May Also Like:

MMWR. Morbidity and mortality weekly report, Vol. 39, no. 25, June 29, 1990

Corporate Author:

Centers for Disease Control (U.S.)

Published:

June 29, 1990

Series:

MMWR. Morbidity and mortality weekly report ; v. 39, no. 25
HHS publication ; no. (CDC) 90-8017

Description:

Reduced incidence of menstrual toxic-shock syndrome--United States, 1980-1990. -- Elemental mercury poisoning in a household--Ohio, 1989. -- Postsurgical infections associated with an extrinsically contaminated intravenous anesthetic agent--Californi...

File Type:

[PDF - 2.68 MB]
Infectious Disease Risk Associated with Contaminated Propofol Anesthesia, 1989–20141

Personal Author:

Zorrilla-Vaca, Andrés; Arevalo, Jimmy J.; Escandón-Vargas, Kevin; Soltanifar, Daniel; Mirski, Marek A.;

Published:

Jun 2016

Source:

Emerg Infect Dis. 22(6):981-992.

Description:

Administration of propofol, the most frequently used intravenous anesthetic worldwide, has been associated with several iatrogenic infections despite its relative safety. Little is known regarding the global epidemiology of propofol-related outbreaks...

File Type:

[PDF - 1.14 MB]
$Refractory Status Epilepticus in Children intentiontotreat with continuous infusions of midazolam and pentobarbital$

Refractory Status Epilepticus in Children: intention-to-treat with continuous infusions of midazolam and pentobarbital

Personal Author:

Tasker, Robert C; Goodkin, Howard P; Fernández, Iván Sánchez; Chapman, Kevin E; Abend, Nicholas S; Arya, Ravindra; Brenton, James N; Carpenter, Jessica L; Gaillard, William D; Glauser, Tracy A; Goldstein, Joshua; Helseth, Ashley R; Jackson, Michele C; Kapur, Kush; Mikati, Mohamad A; Peariso, Katrina; Wainwright, Mark S; Wilfong, Angus A; Williams, Korwyn; Loddenkemper, Tobias;

Published:

Oct 2016

Source:

Pediatr Crit Care Med. 17(10):968-975.

Description:

Objective : To describe pediatric patients with convulsive refractory status epilepticus (RSE) in whom there is intention-to-use an intravenous anesthetic for seizure control. : Design : Two-year prospective observational study evaluating patients (a...

File Type:

[PDF - 248.72 KB]
Contamination identified in additional medical products from New England Compounding Center

Corporate Author:

Centers for Disease Control and Prevention (U.S.). United States. Food and Drug Administration..

Published:

11/1/12

Series:

HAN ; 333

Description:

November 1, 2012, 18:00 ET (6:00 PM ET) : CDC HAN-00333-2012-11 -01-ADV-N : Summary: As part of the ongoing investigation of the multistate outbreak of fungal meningitis and other infections, the Centers for Disease Control and Prevention (CDC) and t...

File Type:

[PDF - 1.53 MB]
Update : Multistate outbreak of fungal meningitis and joint infections associated with contaminated steroid medications

Corporate Author:

Centers for Disease Control and Prevention (U.S.). United States. Food and Drug Administration..

Published:

October 17, 2012

Series:

HAN ; 329

Description:

October 17, 2012, 13:15 (1:15 PM ET) : CDCHAN-00329-2012-10-17-UPD-N : The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) continue to work closely with state public health departments on a multistate inves...

File Type:

[PDF - 2.69 MB]